Search results
Results From The WOW.Com Content Network
A Q2 update about the progress of a late-stage clinical study provides a nice boost to the clinical-stage biotech stock. Why Inovio Pharmaceuticals, Inc. Stock Is Jumping 12.4% Today Skip to main ...
It traded 0.6% lower in the after-hours at $50.20 per share.See more from Benzinga * Another Chinese Bitcoin Mining Device Maker Files To Go Public In US * Amazon Pilots Online Screening Of New ...
For premium support please call: 800-290-4726 more ways to reach us
Investors are not impressed with the biotech's latest plan to raise cash.
And just like that, the tides have turned for Inovio Pharmaceuticals (INO). Shares of the high-flying biotech dropped last week by 31%, the vast majority of which came after the release of interim ...
The more important question is: Why have Inovio's shares fallen for several weeks now?
Inovio Pharmaceuticals (INO) disappoints with earnings and revenue miss in the second quarter. Shares depreciate in after-hours trading. ... Shares depreciate in after-hours trading. Skip to main ...
The stock of Inovio Pharmaceuticals (NAS:INO, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation.